TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Empire Bio A/S
Closing information (x1000 EUR)
| Closing information | 2025/12 | 2024/12 | 2023/12 |
| Turnover |
0
|
0 | |
| Earnings before taxes |
-57
|
-36 | |
| Total assets |
938
|
996 | |
| Current assets |
248
|
301 | |
| Current liabilities |
351
|
364 | |
| Equity capital |
567
|
612 | |
| - share capital |
185
|
185 | |
| Employees (average) |
35
|
35
|
35 |
Financial ratios
| Fiscal year | 2025/12 | 2024/12 | 2023/12 |
| Solvency |
60.4%
|
61.4% | |
| Turnover per employee |
0
|
0 | |
| Profit as a percentage of turnover | |||
| Return on assets (ROA) | |||
| Current ratio |
70.7%
|
82.7% | |
| Return on equity (ROE) |
-10.1%
|
-5.9% | |
| Change turnover |
0
|
0 | |
| Change turnover % | |||
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2025/12 | 2024/12 | 2023/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.